Technical analysis of Oragenics, Inc. (OGEN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option.
Price Performance
| 1 month | -8.42% |
| 3 months | -8.99% |
| Year-to-date | -36.16% |
| 1 year | -60.32% |
| 3 years | -99.46% |
| 5 years | -99.96% |
52-Week Range
| 52-week High | $1.45 |
| 52-week Low | $0.48 |
| Avg Volume (90d) | 39K |
Technical Indicators
| SMA 50 | $0.53 |
| SMA 200 | $0.67 |
| Beta | 1.21 |
| 30-day Volatility (annualised) | 33.3% |
| Price vs SMA 50 | -5.3% |
| Price vs SMA 200 | -25.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.23 | |
| 2025-11 | $0.87 | -29.3% |
| 2025-12 | $0.78 | -10.0% |
| 2026-01 | $0.84 | +7.4% |
| 2026-02 | $0.84 | -0.1% |
| 2026-03 | $0.56 | -33.3% |
| 2026-04 | $0.59 | +6.1% |
| 2026-05 | $0.61 | +2.0% |
| 2026-06 | $0.58 | -4.2% |
| 2026-07 | $0.50 | -13.9% |
| 2026-08 | $0.51 | +2.0% |
| 2026-09 | $0.50 | -1.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.50 |
| Market Cap | $2M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 0.61 |
| EV / EBITDA | 0.22 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 3.01 |